Dr. Erin E. Ducharme, MD

Dr. Ducharme practices at Ducharme Dermatology in Clive, Iowa.

Dr. Ducharme's NPI, 1891961900, was assigned on May 8, 2008. Dr. Ducharme graduated from Vagelos College of Physicians and Surgeons in 2007. Dr. Ducharme holds Iowa license MD-40967.

Dr. Ducharme's primary practice is Ducharme Dermatology, at 16349 Sheridan Ave, Clive, IA 50325 in Polk County. The practice phone is (515) 987-0333.

Dr. Ducharme's primary practice is Ducharme Dermatology in Clive, Iowa. The medical group on file is Ducharme Dermatology. Dmand AI also links Dr. Ducharme to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ducharme practices. Vendor and product names are available with a free account.

Dermatology is Dr. Ducharme's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Ducharme is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Ducharme's licenses on file in 2 states: Iowa and Texas.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, itchy rashes, joint cyst, minor injury to a limb and psoriasis among the conditions Dr. Ducharme treats.

CMS data shows 4,546 Medicare services from Dr. Ducharme across 31 procedure codes in 2024, for 967 Medicare patients. Medicare paid $234,973 for them. Every service was in an office.

CMS counts 967 Medicare patients who saw Dr. Ducharme in 2024. The largest group is 65 to 74, with 518 patients. 72% of them have high cholesterol, and 63% have high blood pressure. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ducharme's median patient age at 59, with 59% women.

In 2024, Dr. Ducharme wrote 977 Medicare Part D claims for 389 patients. 97% of them were for generic drugs. CMS names the drug for 892 of them, across 18 drugs with 11 or more claims each, at $16,613 in total drug cost. In 2023, CMS named 601 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Ducharme for performance year 2024, reported as part of a group. Dr. Ducharme accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ducharme as offering telehealth. CMS counts 1,219 procedures of removal of skin lesions by Dr. Ducharme, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Ducharme. The most frequent topics are Skin Diseases. Dr. Ducharme's most frequent co-authors are Keith Edward Baribault, MD, Danielle E. Engler, MD and Sameera Husain, MD.

CMS Open Payments shows 6 general payments to Dr. Ducharme from 4 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 69% of the total. Revance Therapeutics, Inc. paid the most, $36.

Dr. Ducharme graduated from Vagelos College of Physicians and Surgeons in 2007.

Dr. Ducharme is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.